These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1830 related articles for article (PubMed ID: 32024970)

  • 1. CD8
    van der Leun AM; Thommen DS; Schumacher TN
    Nat Rev Cancer; 2020 Apr; 20(4):218-232. PubMed ID: 32024970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response.
    Reiser J; Banerjee A
    J Immunol Res; 2016; 2016():8941260. PubMed ID: 27314056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral CD8
    Horton BL; Williams JB; Cabanov A; Spranger S; Gajewski TF
    Cancer Immunol Res; 2018 Jan; 6(1):14-24. PubMed ID: 29097422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor.
    Pasetto A; Gros A; Robbins PF; Deniger DC; Prickett TD; Matus-Nicodemos R; Douek DC; Howie B; Robins H; Parkhurst MR; Gartner J; Trebska-McGowan K; Crystal JS; Rosenberg SA
    Cancer Immunol Res; 2016 Sep; 4(9):734-43. PubMed ID: 27354337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-Infiltrating Lymphocytes in the Checkpoint Inhibitor Era.
    Linette GP; Carreno BM
    Curr Hematol Malig Rep; 2019 Aug; 14(4):286-291. PubMed ID: 31187421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion.
    Shakiba M; Zumbo P; Espinosa-Carrasco G; Menocal L; Dündar F; Carson SE; Bruno EM; Sanchez-Rivera FJ; Lowe SW; Camara S; Koche RP; Reuter VP; Socci ND; Whitlock B; Tamzalit F; Huse M; Hellmann MD; Wells DK; Defranoux NA; Betel D; Philip M; Schietinger A
    J Exp Med; 2022 Feb; 219(2):. PubMed ID: 34935874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-Resident Memory T Cells in Cancer Immunosurveillance.
    Park SL; Gebhardt T; Mackay LK
    Trends Immunol; 2019 Aug; 40(8):735-747. PubMed ID: 31255505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Emerging Role of CD8
    Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
    Front Immunol; 2018; 9():1904. PubMed ID: 30158938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial Cancer Suppresses CD8+ T Cell-Mediated Cytotoxicity in Postmenopausal Women.
    Patel MV; Shen Z; Rodriguez-Garcia M; Usherwood EJ; Tafe LJ; Wira CR
    Front Immunol; 2021; 12():657326. PubMed ID: 33968059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression.
    Gao HF; Cheng CS; Tang J; Li Y; Chen H; Meng ZQ; Chen Z; Chen LY
    Aging (Albany NY); 2020 Jan; 12(1):502-517. PubMed ID: 31913856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased level of peripheral CD8
    Li Y; Qian T; Zhao H; Zhang Z; Ming Y; Qiao G; Liu J
    Future Oncol; 2020 Nov; 16(32):2611-2617. PubMed ID: 32820651
    [No Abstract]   [Full Text] [Related]  

  • 12. Bystander CD8
    Simoni Y; Becht E; Fehlings M; Loh CY; Koo SL; Teng KWW; Yeong JPS; Nahar R; Zhang T; Kared H; Duan K; Ang N; Poidinger M; Lee YY; Larbi A; Khng AJ; Tan E; Fu C; Mathew R; Teo M; Lim WT; Toh CK; Ong BH; Koh T; Hillmer AM; Takano A; Lim TKH; Tan EH; Zhai W; Tan DSW; Tan IB; Newell EW
    Nature; 2018 May; 557(7706):575-579. PubMed ID: 29769722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7H4 expression in tumor cells impairs CD8 T cell responses and tumor immunity.
    Zhou L; Ruan M; Liu Y; Zhu Y; Fu D; Wu K; Zhang Q
    Cancer Immunol Immunother; 2020 Feb; 69(2):163-174. PubMed ID: 31848656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory CD8
    Han J; Khatwani N; Searles TG; Turk MJ; Angeles CV
    Semin Immunol; 2020 Jun; 49():101435. PubMed ID: 33272898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Cell Transcriptomic Analysis Reveals a Tumor-Reactive T Cell Signature Associated With Clinical Outcome and Immunotherapy Response In Melanoma.
    Yan M; Hu J; Ping Y; Xu L; Liao G; Jiang Z; Pang B; Sun S; Zhang Y; Xiao Y; Li X
    Front Immunol; 2021; 12():758288. PubMed ID: 34804045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and spatial heterogeneity of CD8
    Sun Y; Yinwang E; Wang S; Wang Z; Wang F; Xue Y; Zhang W; Zhao S; Mou H; Chen S; Jin L; Li B; Ye Z
    Mol Cancer; 2024 Sep; 23(1):193. PubMed ID: 39251981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes.
    Sobral-Leite M; Salomon I; Opdam M; Kruger DT; Beelen KJ; van der Noort V; van Vlierberghe RLP; Blok EJ; Giardiello D; Sanders J; Van de Vijver K; Horlings HM; Kuppen PJK; Linn SC; Schmidt MK; Kok M
    Breast Cancer Res; 2019 Aug; 21(1):90. PubMed ID: 31391067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatin states define tumour-specific T cell dysfunction and reprogramming.
    Philip M; Fairchild L; Sun L; Horste EL; Camara S; Shakiba M; Scott AC; Viale A; Lauer P; Merghoub T; Hellmann MD; Wolchok JD; Leslie CS; Schietinger A
    Nature; 2017 May; 545(7655):452-456. PubMed ID: 28514453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1
    Kurtulus S; Madi A; Escobar G; Klapholz M; Nyman J; Christian E; Pawlak M; Dionne D; Xia J; Rozenblatt-Rosen O; Kuchroo VK; Regev A; Anderson AC
    Immunity; 2019 Jan; 50(1):181-194.e6. PubMed ID: 30635236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
    Li Y; Liu S; Hernandez J; Vence L; Hwu P; Radvanyi L
    J Immunol; 2010 Jan; 184(1):452-65. PubMed ID: 19949105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 92.